Cleaning Validation GMP Under Regulatory Scrutiny
Introduction
During a GMP audit, Cleaning Validation is one of the first dossiers requested.
Not because it is a minor topic, but because it reflects the company’s ability to control contamination risks effectively.
Regulatory Analysis
- EU GMP Annex 15: requirement for HBEL-based limits
- ICH Q9: risk-based approach
- ICH Q10: integration into the Pharmaceutical Quality System (PQS)
- FDA 21 CFR 211.67: written and controlled cleaning procedures
What Inspectors Expect to See
- Scientifically justified MACO calculations
- Recovery studies
- Evidence supporting worst-case selection
- Trending of results over time
- Structured deviation management
How to Avoid Critical Observations
- Always document the scientific rationale
- Demonstrate full lifecycle control
- Integrate change control with Cleaning Validation
- Demonstrate that QA governs the process
Audit Readiness: Essential Documents
- Approved protocol and final report
- Toxicological assessments
- Risk assessments
- Cleaning records and logs
- CAPA and change control documentation
Typical Observation / Corrective Action
Observation: Use of legacy limits without HBEL justification
Corrective Action: Update toxicological evaluation and perform targeted revalidation
Conclusion
Cleaning Validation is a mirror of the quality system.
Keep your organization audit-ready. Discover the complete guide on GuideGxP.com.
